MCM
JAZZ icon

MAI Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

MAI Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$667K Buy
2,767
+1,260
+84% +$276K ﹤0.01% 1161
2026
Q1 		$285K Buy
1,507
+1,289
+591% +$225K ﹤0.01% 1302
2025
Q4 		$37.1K Buy
218
+61
+39% +$9.35K ﹤0.01% 2186
2025
Q3 		$20.7K Buy
157
+22
+16% +$2.64K ﹤0.01% 2389
2025
Q2 		$14.3K Buy
135
+70
+108% +$7.6K ﹤0.01% 2534
2025
Q1 		$8.07K Sell
65
-197
-75% -$25.7K ﹤0.01% 2573
2024
Q4 		$32.3K Buy
+262
New +$30.9K ﹤0.01% 1993
2020
Q2 		– Sell
-4,998
Closed -$499K – 563
2020
Q1 		$499K Buy
4,998
+275
+6% +$35.6K 0.02% 361
2019
Q4 		$705K Sell
4,723
-61
-1% -$8.3K 0.02% 348
2019
Q3 		$613K Buy
4,784
+420
+10% +$56.3K 0.03% 325
2019
Q2 		$622K Buy
4,364
+96
+2% +$12.9K 0.03% 317
2019
Q1 		$610K Sell
4,268
-300
-7% -$39.1K 0.03% 277
2018
Q4 		$566K Sell
4,568
-64
-1% -$9.49K 0.03% 285
2018
Q3 		$779K Sell
4,632
-241
-5% -$41.4K 0.04% 265
2018
Q2 		$840K Buy
+4,873
New +$797K 0.05% 238

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

MAI Capital Management's JAZZ Position: Q2 2026 in Review

MAI Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 84% in Q2 2026, buying an estimated $276K and bringing the position to 2,767 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

MAI Capital Management first reported a position in JAZZ in Q2 2018 and has held it in 15 quarters since. The position peaked at $840K in Q2 2018. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • MAI Capital Management held 2,767 shares of Jazz Pharmaceuticals worth $667K as of Q2 2026.
  • MAI Capital Management bought 1,260 Jazz Pharmaceuticals shares in Q2 2026, an estimated $276K.
  • Jazz Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1161 holding.
  • MAI Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 15 quarters since.
  • MAI Capital Management's Jazz Pharmaceuticals position peaked at $840K in Q2 2018.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.